Time-dependent retention and discontinuation of eslicarbazepine acetate treatment in real-world focal epilepsy: The first three months as a key period

Clinical Neurology and Neurosurgery · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles